Biological Samples Collection From Patients and Caregivers Treated at Bordeaux University Hospital for Asymptomatic and Symptomatic Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) Infection (COVID-19).
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Infection Viral
- Sponsor
- University Hospital, Bordeaux
- Enrollment
- 2000
- Locations
- 1
- Primary Endpoint
- COVID-19 desease description
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
The coronavirus disease 2019 (COVID-19) outbreak is now considered as a public health emergency of international concern by the World Health Organization.
In the context of the health emergency, research on the pathogen (the SARS-CoV-2 coronavirus), the disease and the therapeutic care is being organized. Research projects require the use of biological samples. This study aims at setting up a collection of biological samples intended for application projects in any discipline.
The main objective of the study is to collect, process and store biological samples from patients and caregivers infected with SARS-CoV-2 (COVID-19) at the biological ressources center of the Bordeaux University Hospital.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients / caregivers treated at Bordeaux University Hospital for asymptomatic or symptomatic infection by SARS -CoV-2
- •men and women, adults and minors as well as pregnant or breastfeeding women
- •patients who died following infection with SARS-CoV-2 (specific criterion for post-mortem biopsies)
- •Be affiliated with or beneficiary of a social security scheme
- •Free and informed consent obtained and signed by the patient
Exclusion Criteria
- •Under guardianship or curatorship
Outcomes
Primary Outcomes
COVID-19 desease description
Time Frame: Day 30 to 90
From blood samples: protein levels.